Article
PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
Clinical & developmental immunology - 1 Jan 2013
Zavala-Cerna Maria Guadalupe, Gonzalez-Montoya Norma Guadalupe, Nava Arnulfo, Gamez-Nava Jorge I, Moran-Moguel Maria Cristina, Rosales-Gomez Roberto Carlos, Gutierrez-Rubio Susan Andrea, Sanchez-Corona Jose, Gonzalez-Lopez Laura, Davalos-Rodriguez Ingrid Patricia, Salazar-Paramo Mario
Abstract excerpt
Peptidyl arginine deiminase IV (PAD 4) is the responsible enzyme for a posttranslational modification called citrullination, originating the antigenic determinant recognized by anti-cyclic citrullinated peptide antibodies (ACPA). Four SNPs (single nucleotide polymorphisms) have been described in PADI4 gene to form a susceptibility haplotype for rheumatoid arthritis (RA); nevertheless, results in association...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
